GEN - Genetic Engineering and Biotechnology News
Get the latest news and information on genetic engineering and biotechnology including analysis, features, webinars, podcasts, and more.
Top 25 Biotech Companies of 2024 - genengnews.com
Jan 12, 2024 · However, biotechnology remains a profitable investment in the long term. Over the past five years, the market cap for the top 25 biotechnology companies soared nearly 78% from the combined $963. ...
Top 10 Contract Development and Manufacturing Organizations …
Aug 23, 2024 · This year, GEN’s list of top 10 contract development and manufacturing organizations is led by Lonza, which works across five continents and relies on a global community of around 18,000 ...
Top 10 Biopharma Takeover Targets of 2024 - genengnews.com
Feb 1, 2024 · Viewed simply by numbers of merger and acquisition (M&A) deals, 2023 was a down year: 1,078 biotech companies found buyers last year, down from 1,088 in 2022, while the number of pharma companies ...
Targeting “Proteolethargy” to Restore Protein Mobility May …
Nov 27, 2024 · The newly reported study focused on protein mobility in the context of chronic diseases. The scientists explained that the billions of protein molecules produced in cells must leave their site of ...
StockWatch: Turnaround Lifts GeneDx Stock 3,600%, with …
Sep 30, 2024 · A 45% jump in revenue to $70.514 million, nearly all of it ($68.924 million) revenue from continuing operations at adjusted gross margins of 62%.
Top 10 RNA-Based Biopharmas - genengnews.com
Nov 17, 2021 · In GEN’s initial A-List published in 2018, the top five public companies generated a combined $1.536 billion in revenues for 2017 and the first three quarters of 2018.By contrast, the top five ...
Recursion to Acquire Exscientia, Combining AI Drug Pioneers
Aug 8, 2024 · Two months earlier, Exscientia pruned its pipeline down to four active drug candidates in therapeutic areas that include inflammatory disease, hematology, and most notably, oncology.. The value of ...
Genes Activating Old Neural Stem Cells May Counteract Decline …
Oct 2, 2024 · The study results could point to some intriguing next steps in addressing this old neural stem cell passivity—or even stimulating neurogenesis in younger brains in need of repair— by targeting ...
Wave Clinical Trial Shows First Successful RNA Editing in Humans
Oct 16, 2024 · Wave Life Sciences said today its alpha-1 antitrypsin deficiency (AATD) candidate WVE-006 succeeded in the first-ever clinical demonstration of RNA editing in humans by achieving positive proof-of ...